Robert L. Saylors

Cyclophosphamide Plus Topotecan in Children With Recurrent or Refractory Solid Tumors: A Pediatric Oncology Group Phase II Study

Robert L. Saylors, Kimo C. Stine, Jim Sullivan et al. · Journal of Clinical Oncology · 2001 · 314 citations

STAT3 Activation in Stromal/Osteoblastic Cells Is Required for Induction of the Receptor Activator of NF-κB Ligand and Stimulation of Osteoclastogenesis by gp130-utilizing Cytokines or Interleukin-1 but Not 1,25-Dihydroxyvitamin D3 or Parathyroid Hormone

Charles A. O’Brien, Igor Gubrij, Song-Chang Lin et al. · Journal of Biological Chemistry · 1999 · 313 citations · Full text

Technetium-99m sestamibi myocardial perfusion imaging in the emergency room evaluation of chest pain

Thomas C. Hilton, Randall C. Thompson, Hugh J. Williams et al. · Journal of the American College of Cardiology · 1994 · 257 citations

Emergency Radiology, Health Sciences, Medical Imaging +9

Infrequent p53 gene mutations in medulloblastomas.

Robert L. Saylors, David Sidransky, H. S. Friedman et al. · PubMed · 1991 · 190 citations

Tumor Biology, P53 Mutations, Tumor Heterogeneity +10

Neuroblastoma: Effect of genetic factors on prognosis and treatment

Garrett M. Brodeur, C G Azar, Michele B. Brother et al. · Cancer · 1992 · 149 citations · Full text

Pathology, Neural Stem Cell, Genetic Factors +17